Haemonetics (HAE) Tops Q2 EPS by 7c, Beats on Revenues
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.73 +0.30%
Revenue Growth %: +5.5%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +5.5%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.48, $0.07 better than the analyst estimate of $0.41. Revenue for the quarter came in at $225 million versus the consensus estimate of $219.26 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan
- HP Inc. projects mid-single-digit PC market decline in 2027
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
